Newsfeeds - Spark Newswire

1 minute read

$1000 Invested In Eli Lilly 10 Years Ago Would Be Worth This Much Today

Today, 3:03 PM

Eli Lilly (NYSE:LLY) has outperformed the market over the past 10 years by 10.04% on an annualized basis producing an average annual return of 20.46%. Currently, Eli Lilly has a market capitalization of $290.05 billion.

LLY

1 minute read

US Department Of Health, Defense To Inject $1B To Boost Domestic Biomanufacturing

By Vandana Singh

Today, 3:03 PM

As part of President Joe Biden’s executive order to beef up U.S. biomanufacturing, the U.S. Department of Health and Human…

ABBV

1 minute read

Biden Administration Pushes ‘Cancer Moonshot’ Initiative: Report

By Vandana Singh

Today, 3:03 PM

President Joe Biden channeled John F. Kennedy on the 60th anniversary of the former President's moonshot speech, highlighting the Biden administration's efforts to "end cancer as we know it." The President underscored his goal to cut the cancer death rate in the U.S. by at least 50% over the next 25 years.

ABBV

2 minute read

Eli Lilly Whale Trades Spotted

By Benzinga Insights

Today, 3:03 PM

A whale with a lot of money to spend has taken a noticeably bullish stance on Eli Lilly. Looking at options history for Eli Lilly (NYSE:LLY) we detected 15 strange trades.

LLY

5 minute read

Junshi Biosciences Hits Revenue Roadblock Amid Covid Drug Delay

By The Bamboo Works

Today, 3:03 PM

Key Takeaways: The company logged a revenue fall of 55% in the first half of the year and posted a loss of $131 million Phase 3 clinical trials for its Covid-19 oral drug wrapped up in May but the company has still not yet filed an application to market the product By Molly Wen

BGNE

2 minute read

Tesla Fame’s Robot-Run ETF Sold Its Entire Apple Stake In August — Here’s What It Bought

By Shanthi Rexaline

Today, 3:03 PM

A large-cap-momentum-focused, AI-powered exchange-traded fund (ETF) sponsored by Qraft Technologies shed its entire Apple Inc. (NASDAQ: AAPL) stake in August, according to an update on monthly holdings issued by the South Korea-based company.

AAPL

4 minute read

Important Biotech Catalysts For September 8, 2022 – End Of The Day Summary

By Ragothaman Srinivasan

Today, 3:03 PM

The United States Food and Drug Administration (FDA) has approved Revance Therapeutics’ (NASDAQ:RVNC) lead asset DAXXIFY (DaxibotulinumtoxinA-lanm) for…

ALNY

1 minute read

FDA
News

Eli Lilly Says Lebrikizumab Dosed Every Four Weeks Maintained Durable Skin Clearance in Lilly’s Phase 3 Monotherapy Atopic Dermatitis Trials

By Benzinga Newsdesk

Today, 3:03 PM

New, late-breaking data show lebrikizumab responders reported long-lasting results at one year of treatment across measures of improvement in skin clearance, itch and disease extent and severity Results suggest less

LLY

2 minute read

Events
News

Lilly Announced Details of Presentations at ESMO Congress 2022

By Charles Gross

Today, 3:03 PM

Eli Lilly and Company (NYSE: LLY) today announced that data from studies of Verzenio® (abemaciclib) and Retevmo® (selpercatinib) will be presented at the 2022 European Society for Medical Oncology (ESMO) Congress, to be held September 9-13, 2022. Presentation Highlights Verzenio (abemaciclib)

LLY

1 minute read

Analyst Ratings

Expert Ratings for Eli Lilly

By Benzinga Insights

Today, 3:03 PM

Over the past 3 months, 4 analysts have published their opinion on Eli Lilly (NYSE:LLY) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

LLY